nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Carboplatin—uterine cancer	0.42	0.6	CbGbCtD
Cefdinir—SLC22A5—Dactinomycin—uterine cancer	0.28	0.4	CbGbCtD
Cefdinir—MPO—artery—uterine cancer	0.00709	0.15	CbGeAlD
Cefdinir—SLC15A1—epithelium—uterine cancer	0.00299	0.0633	CbGeAlD
Cefdinir—SLC15A1—renal system—uterine cancer	0.00277	0.0587	CbGeAlD
Cefdinir—MPO—epithelium—uterine cancer	0.00269	0.057	CbGeAlD
Cefdinir—SLC15A1—endometrium—uterine cancer	0.00268	0.0568	CbGeAlD
Cefdinir—SLC15A1—mammalian vulva—uterine cancer	0.00259	0.0549	CbGeAlD
Cefdinir—MPO—renal system—uterine cancer	0.00249	0.0528	CbGeAlD
Cefdinir—SLC22A5—myometrium—uterine cancer	0.00207	0.0439	CbGeAlD
Cefdinir—SLC15A1—vagina—uterine cancer	0.00201	0.0425	CbGeAlD
Cefdinir—SLC15A2—uterine cervix—uterine cancer	0.00185	0.0392	CbGeAlD
Cefdinir—SLC15A2—renal system—uterine cancer	0.00173	0.0367	CbGeAlD
Cefdinir—SLC15A2—endometrium—uterine cancer	0.00167	0.0355	CbGeAlD
Cefdinir—SLC22A5—uterine cervix—uterine cancer	0.00161	0.0341	CbGeAlD
Cefdinir—SLC22A5—renal system—uterine cancer	0.00151	0.0319	CbGeAlD
Cefdinir—SLC22A5—endometrium—uterine cancer	0.00146	0.0309	CbGeAlD
Cefdinir—SLC15A2—female reproductive system—uterine cancer	0.00139	0.0294	CbGeAlD
Cefdinir—SLC15A2—female gonad—uterine cancer	0.00126	0.0268	CbGeAlD
Cefdinir—SLC15A2—vagina—uterine cancer	0.00125	0.0266	CbGeAlD
Cefdinir—SLC22A5—female reproductive system—uterine cancer	0.00121	0.0256	CbGeAlD
Cefdinir—MPO—lymph node—uterine cancer	0.00117	0.0248	CbGeAlD
Cefdinir—SLC22A5—female gonad—uterine cancer	0.0011	0.0233	CbGeAlD
Cefdinir—SLC22A5—vagina—uterine cancer	0.00109	0.0231	CbGeAlD
Cefdinir—Candida infection—Etoposide—uterine cancer	0.00106	0.00419	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Doxorubicin—uterine cancer	0.00106	0.00417	CcSEcCtD
Cefdinir—Erythema multiforme—Progesterone—uterine cancer	0.00103	0.00408	CcSEcCtD
Cefdinir—Vaginal discharge—Epirubicin—uterine cancer	0.00102	0.00405	CcSEcCtD
Cefdinir—Rash maculo-papular—Etoposide—uterine cancer	0.00101	0.00399	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.001	0.00397	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.001	0.00397	CcSEcCtD
Cefdinir—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000994	0.00393	CcSEcCtD
Cefdinir—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000989	0.00391	CcSEcCtD
Cefdinir—Vaginal discharge—Doxorubicin—uterine cancer	0.000948	0.00375	CcSEcCtD
Cefdinir—Flatulence—Progesterone—uterine cancer	0.000937	0.0037	CcSEcCtD
Cefdinir—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00369	CcSEcCtD
Cefdinir—Pancytopenia—Dactinomycin—uterine cancer	0.000916	0.00362	CcSEcCtD
Cefdinir—Neutropenia—Dactinomycin—uterine cancer	0.000902	0.00356	CcSEcCtD
Cefdinir—Ileus—Epirubicin—uterine cancer	0.000881	0.00348	CcSEcCtD
Cefdinir—Pneumonia—Dactinomycin—uterine cancer	0.000865	0.00342	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000852	0.00337	CcSEcCtD
Cefdinir—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.00335	CcSEcCtD
Cefdinir—Stomatitis—Dactinomycin—uterine cancer	0.000838	0.00331	CcSEcCtD
Cefdinir—Loss of consciousness—Progesterone—uterine cancer	0.000835	0.0033	CcSEcCtD
Cefdinir—Cardiac failure—Etoposide—uterine cancer	0.000827	0.00327	CcSEcCtD
Cefdinir—Convulsion—Progesterone—uterine cancer	0.000823	0.00325	CcSEcCtD
Cefdinir—Hypertension—Progesterone—uterine cancer	0.000821	0.00324	CcSEcCtD
Cefdinir—Ileus—Doxorubicin—uterine cancer	0.000815	0.00322	CcSEcCtD
Cefdinir—SLC15A2—lymph node—uterine cancer	0.000811	0.0172	CbGeAlD
Cefdinir—Chest pain—Progesterone—uterine cancer	0.000809	0.0032	CcSEcCtD
Cefdinir—Agranulocytosis—Dactinomycin—uterine cancer	0.000802	0.00317	CcSEcCtD
Cefdinir—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00313	CcSEcCtD
Cefdinir—Dry mouth—Progesterone—uterine cancer	0.000791	0.00313	CcSEcCtD
Cefdinir—Anaphylactic shock—Progesterone—uterine cancer	0.000776	0.00306	CcSEcCtD
Cefdinir—Shock—Progesterone—uterine cancer	0.000763	0.00301	CcSEcCtD
Cefdinir—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000757	0.00299	CcSEcCtD
Cefdinir—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00295	CcSEcCtD
Cefdinir—Anorexia—Progesterone—uterine cancer	0.000739	0.00292	CcSEcCtD
Cefdinir—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.0029	CcSEcCtD
Cefdinir—Erythema multiforme—Dactinomycin—uterine cancer	0.00073	0.00288	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000727	0.00287	CcSEcCtD
Cefdinir—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000717	0.00283	CcSEcCtD
Cefdinir—SLC22A5—lymph node—uterine cancer	0.000706	0.015	CbGeAlD
Cefdinir—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000703	0.00278	CcSEcCtD
Cefdinir—Insomnia—Progesterone—uterine cancer	0.000702	0.00277	CcSEcCtD
Cefdinir—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000692	0.00273	CcSEcCtD
Cefdinir—Somnolence—Progesterone—uterine cancer	0.00069	0.00272	CcSEcCtD
Cefdinir—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000688	0.00272	CcSEcCtD
Cefdinir—Dyspepsia—Progesterone—uterine cancer	0.000683	0.0027	CcSEcCtD
Cefdinir—Decreased appetite—Progesterone—uterine cancer	0.000674	0.00266	CcSEcCtD
Cefdinir—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00067	0.00265	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Progesterone—uterine cancer	0.00067	0.00265	CcSEcCtD
Cefdinir—Dyskinesia—Epirubicin—uterine cancer	0.000663	0.00262	CcSEcCtD
Cefdinir—Constipation—Progesterone—uterine cancer	0.000663	0.00262	CcSEcCtD
Cefdinir—Pancytopenia—Etoposide—uterine cancer	0.000663	0.00262	CcSEcCtD
Cefdinir—Neutropenia—Etoposide—uterine cancer	0.000652	0.00258	CcSEcCtD
Cefdinir—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00251	CcSEcCtD
Cefdinir—Gastrointestinal pain—Progesterone—uterine cancer	0.000634	0.00251	CcSEcCtD
Cefdinir—Pneumonia—Etoposide—uterine cancer	0.000626	0.00247	CcSEcCtD
Cefdinir—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000625	0.00247	CcSEcCtD
Cefdinir—Vaginal inflammation—Epirubicin—uterine cancer	0.000623	0.00246	CcSEcCtD
Cefdinir—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00244	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000617	0.00244	CcSEcCtD
Cefdinir—Dyskinesia—Doxorubicin—uterine cancer	0.000614	0.00242	CcSEcCtD
Cefdinir—Acute coronary syndrome—Etoposide—uterine cancer	0.000613	0.00242	CcSEcCtD
Cefdinir—Abdominal pain—Progesterone—uterine cancer	0.000613	0.00242	CcSEcCtD
Cefdinir—Body temperature increased—Progesterone—uterine cancer	0.000613	0.00242	CcSEcCtD
Cefdinir—Renal failure—Etoposide—uterine cancer	0.000612	0.00242	CcSEcCtD
Cefdinir—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000611	0.00241	CcSEcCtD
Cefdinir—Myocardial infarction—Etoposide—uterine cancer	0.00061	0.00241	CcSEcCtD
Cefdinir—Melaena—Epirubicin—uterine cancer	0.000609	0.00241	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.0024	CcSEcCtD
Cefdinir—Stomatitis—Etoposide—uterine cancer	0.000606	0.0024	CcSEcCtD
Cefdinir—Jaundice—Etoposide—uterine cancer	0.000606	0.0024	CcSEcCtD
Cefdinir—Leukopenia—Dactinomycin—uterine cancer	0.000601	0.00238	CcSEcCtD
Cefdinir—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000601	0.00237	CcSEcCtD
Cefdinir—Candida infection—Epirubicin—uterine cancer	0.000595	0.00235	CcSEcCtD
Cefdinir—Vaginal infection—Epirubicin—uterine cancer	0.000589	0.00232	CcSEcCtD
Cefdinir—Aplastic anaemia—Epirubicin—uterine cancer	0.000585	0.00231	CcSEcCtD
Cefdinir—Agranulocytosis—Etoposide—uterine cancer	0.000581	0.00229	CcSEcCtD
Cefdinir—Vaginal inflammation—Doxorubicin—uterine cancer	0.000577	0.00228	CcSEcCtD
Cefdinir—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00227	CcSEcCtD
Cefdinir—Hypersensitivity—Progesterone—uterine cancer	0.000571	0.00226	CcSEcCtD
Cefdinir—Rash maculo-papular—Epirubicin—uterine cancer	0.000567	0.00224	CcSEcCtD
Cefdinir—Melaena—Doxorubicin—uterine cancer	0.000563	0.00223	CcSEcCtD
Cefdinir—Asthenia—Progesterone—uterine cancer	0.000557	0.0022	CcSEcCtD
Cefdinir—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00219	CcSEcCtD
Cefdinir—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00219	CcSEcCtD
Cefdinir—Candida infection—Doxorubicin—uterine cancer	0.000551	0.00218	CcSEcCtD
Cefdinir—Pruritus—Progesterone—uterine cancer	0.000549	0.00217	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—uterine cancer	0.000545	0.00215	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—uterine cancer	0.000542	0.00214	CcSEcCtD
Cefdinir—Thrombocytopenia—Dactinomycin—uterine cancer	0.000537	0.00212	CcSEcCtD
Cefdinir—Diarrhoea—Progesterone—uterine cancer	0.000531	0.0021	CcSEcCtD
Cefdinir—Erythema multiforme—Etoposide—uterine cancer	0.000528	0.00209	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—uterine cancer	0.000524	0.00207	CcSEcCtD
Cefdinir—Anorexia—Dactinomycin—uterine cancer	0.000523	0.00206	CcSEcCtD
Cefdinir—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000518	0.00205	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—uterine cancer	0.000518	0.00205	CcSEcCtD
Cefdinir—Dizziness—Progesterone—uterine cancer	0.000513	0.00203	CcSEcCtD
Cefdinir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00199	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—uterine cancer	0.000504	0.00199	CcSEcCtD
Cefdinir—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000497	0.00196	CcSEcCtD
Cefdinir—Vomiting—Progesterone—uterine cancer	0.000493	0.00195	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—uterine cancer	0.00049	0.00194	CcSEcCtD
Cefdinir—Rash—Progesterone—uterine cancer	0.000489	0.00193	CcSEcCtD
Cefdinir—Dermatitis—Progesterone—uterine cancer	0.000489	0.00193	CcSEcCtD
Cefdinir—Headache—Progesterone—uterine cancer	0.000486	0.00192	CcSEcCtD
Cefdinir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.0019	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00048	0.00189	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000479	0.00189	CcSEcCtD
Cefdinir—Decreased appetite—Dactinomycin—uterine cancer	0.000477	0.00188	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—uterine cancer	0.000476	0.00188	CcSEcCtD
Cefdinir—Purpura—Epirubicin—uterine cancer	0.00047	0.00185	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—uterine cancer	0.000466	0.00184	CcSEcCtD
Cefdinir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000465	0.00184	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—uterine cancer	0.000464	0.00183	CcSEcCtD
Cefdinir—Nausea—Progesterone—uterine cancer	0.000461	0.00182	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—uterine cancer	0.000454	0.00179	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000448	0.00177	CcSEcCtD
Cefdinir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000447	0.00177	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000444	0.00175	CcSEcCtD
Cefdinir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00175	CcSEcCtD
Cefdinir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00175	CcSEcCtD
Cefdinir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.00174	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—uterine cancer	0.00044	0.00174	CcSEcCtD
Cefdinir—Leukopenia—Etoposide—uterine cancer	0.000435	0.00172	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—uterine cancer	0.000434	0.00172	CcSEcCtD
Cefdinir—Body temperature increased—Dactinomycin—uterine cancer	0.000433	0.00171	CcSEcCtD
Cefdinir—Abdominal pain—Dactinomycin—uterine cancer	0.000433	0.00171	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—uterine cancer	0.000429	0.00169	CcSEcCtD
Cefdinir—Loss of consciousness—Etoposide—uterine cancer	0.000427	0.00169	CcSEcCtD
Cefdinir—Convulsion—Etoposide—uterine cancer	0.000421	0.00166	CcSEcCtD
Cefdinir—Hypertension—Etoposide—uterine cancer	0.00042	0.00166	CcSEcCtD
Cefdinir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000417	0.00165	CcSEcCtD
Cefdinir—Chest pain—Etoposide—uterine cancer	0.000414	0.00163	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000408	0.00161	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000408	0.00161	CcSEcCtD
Cefdinir—Hypersensitivity—Dactinomycin—uterine cancer	0.000404	0.0016	CcSEcCtD
Cefdinir—Anaphylactic shock—Etoposide—uterine cancer	0.000397	0.00157	CcSEcCtD
Cefdinir—Asthenia—Dactinomycin—uterine cancer	0.000393	0.00155	CcSEcCtD
Cefdinir—Asthma—Epirubicin—uterine cancer	0.000391	0.00154	CcSEcCtD
Cefdinir—Thrombocytopenia—Etoposide—uterine cancer	0.000389	0.00153	CcSEcCtD
Cefdinir—Anorexia—Etoposide—uterine cancer	0.000378	0.00149	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000377	0.00149	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000377	0.00149	CcSEcCtD
Cefdinir—Diarrhoea—Dactinomycin—uterine cancer	0.000375	0.00148	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—uterine cancer	0.000371	0.00147	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—uterine cancer	0.000366	0.00144	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—uterine cancer	0.000362	0.00143	CcSEcCtD
Cefdinir—Somnolence—Etoposide—uterine cancer	0.000353	0.00139	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—uterine cancer	0.000351	0.00139	CcSEcCtD
Cefdinir—Vomiting—Dactinomycin—uterine cancer	0.000349	0.00138	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000346	0.00137	CcSEcCtD
Cefdinir—Rash—Dactinomycin—uterine cancer	0.000346	0.00137	CcSEcCtD
Cefdinir—Decreased appetite—Etoposide—uterine cancer	0.000345	0.00136	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—uterine cancer	0.000344	0.00136	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—uterine cancer	0.000343	0.00135	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000343	0.00135	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—uterine cancer	0.00034	0.00134	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—uterine cancer	0.00034	0.00134	CcSEcCtD
Cefdinir—Constipation—Etoposide—uterine cancer	0.000339	0.00134	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—uterine cancer	0.000339	0.00134	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—uterine cancer	0.000338	0.00134	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—uterine cancer	0.000333	0.00131	CcSEcCtD
Cefdinir—Nausea—Dactinomycin—uterine cancer	0.000326	0.00129	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—uterine cancer	0.000325	0.00129	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—uterine cancer	0.000325	0.00128	CcSEcCtD
Cefdinir—Gastrointestinal pain—Etoposide—uterine cancer	0.000324	0.00128	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00032	0.00126	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—uterine cancer	0.000317	0.00125	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—uterine cancer	0.000315	0.00124	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—uterine cancer	0.000315	0.00124	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—uterine cancer	0.000315	0.00124	CcSEcCtD
Cefdinir—Body temperature increased—Etoposide—uterine cancer	0.000314	0.00124	CcSEcCtD
Cefdinir—Abdominal pain—Etoposide—uterine cancer	0.000314	0.00124	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—uterine cancer	0.000314	0.00124	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—uterine cancer	0.000313	0.00124	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—uterine cancer	0.000308	0.00122	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—uterine cancer	0.000301	0.00119	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—uterine cancer	0.000296	0.00117	CcSEcCtD
Cefdinir—Hypersensitivity—Etoposide—uterine cancer	0.000292	0.00115	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—uterine cancer	0.000291	0.00115	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—uterine cancer	0.00029	0.00114	CcSEcCtD
Cefdinir—Asthenia—Etoposide—uterine cancer	0.000285	0.00112	CcSEcCtD
Cefdinir—Pruritus—Etoposide—uterine cancer	0.000281	0.00111	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—uterine cancer	0.000274	0.00108	CcSEcCtD
Cefdinir—Diarrhoea—Etoposide—uterine cancer	0.000271	0.00107	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—uterine cancer	0.000269	0.00106	CcSEcCtD
Cefdinir—Dizziness—Etoposide—uterine cancer	0.000262	0.00104	CcSEcCtD
Cefdinir—Vomiting—Etoposide—uterine cancer	0.000252	0.000997	CcSEcCtD
Cefdinir—Agitation—Epirubicin—uterine cancer	0.00025	0.000989	CcSEcCtD
Cefdinir—Rash—Etoposide—uterine cancer	0.00025	0.000988	CcSEcCtD
Cefdinir—Dermatitis—Etoposide—uterine cancer	0.00025	0.000987	CcSEcCtD
Cefdinir—Headache—Etoposide—uterine cancer	0.000249	0.000982	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—uterine cancer	0.000248	0.000982	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—uterine cancer	0.000244	0.000964	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—uterine cancer	0.00024	0.000946	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—uterine cancer	0.000236	0.000933	CcSEcCtD
Cefdinir—Nausea—Etoposide—uterine cancer	0.000236	0.000931	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—uterine cancer	0.000235	0.000929	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—uterine cancer	0.000232	0.000916	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—uterine cancer	0.000232	0.000915	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—uterine cancer	0.000227	0.000896	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—uterine cancer	0.000226	0.000892	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—uterine cancer	0.000222	0.000879	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—uterine cancer	0.000222	0.000875	CcSEcCtD
Cefdinir—Shock—Epirubicin—uterine cancer	0.000219	0.000864	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—uterine cancer	0.000218	0.000863	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—uterine cancer	0.000218	0.00086	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—uterine cancer	0.000218	0.00086	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—uterine cancer	0.000215	0.000848	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—uterine cancer	0.000212	0.000837	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—uterine cancer	0.00021	0.000829	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—uterine cancer	0.000206	0.000813	CcSEcCtD
Cefdinir—Shock—Doxorubicin—uterine cancer	0.000202	0.0008	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000202	0.000796	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—uterine cancer	0.000201	0.000795	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—uterine cancer	0.000198	0.000781	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—uterine cancer	0.000196	0.000775	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—uterine cancer	0.000196	0.000773	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—uterine cancer	0.000193	0.000764	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000192	0.000759	CcSEcCtD
Cefdinir—Constipation—Epirubicin—uterine cancer	0.00019	0.000751	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—uterine cancer	0.000186	0.000735	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—uterine cancer	0.000183	0.000723	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000182	0.000718	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—uterine cancer	0.000181	0.000716	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—uterine cancer	0.000179	0.000707	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000178	0.000702	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—uterine cancer	0.000176	0.000695	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—uterine cancer	0.000176	0.000695	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—uterine cancer	0.000176	0.000695	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000168	0.000665	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—uterine cancer	0.000164	0.000647	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—uterine cancer	0.000163	0.000643	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—uterine cancer	0.000163	0.000643	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—uterine cancer	0.00016	0.00063	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—uterine cancer	0.000157	0.000622	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—uterine cancer	0.000152	0.000601	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—uterine cancer	0.000152	0.000599	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—uterine cancer	0.000148	0.000583	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—uterine cancer	0.000147	0.000581	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—uterine cancer	0.000146	0.000575	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—uterine cancer	0.000141	0.000559	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—uterine cancer	0.000141	0.000556	CcSEcCtD
Cefdinir—Rash—Epirubicin—uterine cancer	0.00014	0.000554	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—uterine cancer	0.00014	0.000553	CcSEcCtD
Cefdinir—Headache—Epirubicin—uterine cancer	0.000139	0.00055	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—uterine cancer	0.000136	0.000538	CcSEcCtD
Cefdinir—Nausea—Epirubicin—uterine cancer	0.000132	0.000522	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—uterine cancer	0.000131	0.000517	CcSEcCtD
Cefdinir—Rash—Doxorubicin—uterine cancer	0.00013	0.000513	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—uterine cancer	0.00013	0.000512	CcSEcCtD
Cefdinir—Headache—Doxorubicin—uterine cancer	0.000129	0.000509	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—uterine cancer	0.000122	0.000483	CcSEcCtD
